US Patent 10239837 Piperidine derivatives as HDAC1/2 inhibitors
Patent 10239837 was granted and assigned to Regenacy Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 29, 2017
Date of Patent
March 26, 2019
Patent Applicant
Patent Application Number
15719748
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10239837 Piperidine derivatives as HDAC1/2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.